ArticleThe oncologist2020

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Gabriella Macchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.